Cargando…
ATP12A promotes mucus dysfunction during Type 2 airway inflammation
Allergic airway disease is known to cause significant morbidity due to impaired mucociliary clearance, however the mechanism that leads to the mucus dysfunction is not entirely understood. Interleukin 13 (IL-13), a key mediator of Type 2 (T2) inflammation, profoundly alters the ion transport propert...
Autores principales: | Lennox, Alison T., Coburn, Stefanie L., Leech, John A., Heidrich, Elisa M., Kleyman, Thomas R., Wenzel, Sally E., Pilewski, Joseph M., Corcoran, Timothy E., Myerburg, Mike M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794982/ https://www.ncbi.nlm.nih.gov/pubmed/29391451 http://dx.doi.org/10.1038/s41598-018-20444-8 |
Ejemplares similares
-
Liquid hyper-absorption as a cause of increased DTPA clearance in the cystic fibrosis airway
por: Corcoran, Timothy E, et al.
Publicado: (2013) -
Staphylococcus aureus Biofilm Growth on Cystic Fibrosis Airway Epithelial Cells Is Enhanced during Respiratory Syncytial Virus Coinfection
por: Kiedrowski, Megan R., et al.
Publicado: (2018) -
CFTR Modulators to the Rescue of Individuals with Cystic Fibrosis and Advanced Lung Disease
por: Myerburg, Mike, et al.
Publicado: (2021) -
Airway Mucus Dysfunction in COVID-19
por: Dickey, Burton F., et al.
Publicado: (2022) -
Effect of epithelium ATP release on cyclic pressure-induced airway mucus secretion
por: Tong, Jin, et al.
Publicado: (2014)